Fluxion Biosciences introduced the BioFlux platform, which automates and combines microfluidic chambers, for automated biofilm analysis. Lab901 launched the ScreenTape system for fully automated gel electrophoresis. It consists of the TapeStation system, ScreenTape consumables and software.
London, UK 9/19/07—Whatman has begun a three-year overhaul of operations, following completion of a strategic review. The announcement was made during the company’s review of first-half results (see page 12). The three-phase plan is designed to produce an £8 million ($16.0 million) increase in annual profits. In the first phase, Whatman has begun to address […]
According to data published in September by the German Federal Ministry of Education and Research (BMBF) and the Stifterverband, the German association of research sponsors, public and private R&D spending is increasing. Public R&D funding is expected to increase 8% to €9.2 billion ($12.9 billion) in 2008. The Stifterverband calculates that industry R&D spending grew […]
France’s 2008 budget, which was announced this month, provides a €1.88 billion ($2.66 billion) boost to the budget for higher education and research, an increase of 7.8%. From this funding increase, €1 billion ($1.4 billion) will go to higher education and €880 million ($1.2 billion) will go to research. Funding for research includes a €22 […]
Reichert Analytical Instruments licensed the University of Buffalo’s technology for the creation of a cell volume cytometer for research and diagnostic applications. Amaxa AG is one of eight companies involved in the EU’s MODEST-EU project to develop devices for ultra high-throughput delivery and screening of primary cells. Accuri Cytometers named George Dunbar, president and CEO […]
The construction of new laboratories is growing in Asia, driven by government funding (see page 7) and manufacturing and R&D investment from the West. China’s Ministry of Science and Technology alone has approved the construction of 27 “national key laboratories” this year. China’s Ministry of Commerce reported this month that over 1,000 R&D centers have […]
For companies in the instrument industry, protecting patents is a crucial aspect of business. As was the case in last year’s article (see IBO 11/30/06), Bio-Rad, Applied Biosystems and Invitrogen continue to be among the most legally aggressive companies. First, to begin on a positive note, Bio-Rad’s suit against 4titude and Phenix Research Products was […]
On September 18, on the heels of a market correction, the Federal Reserve cut the Fed funds rate by a surprising half-point to 4.75%, sending the Dow, S&P 500 and NASDAQ up 2.5%, 2.9% and 2.7%, respectively. Signs of a slowing economy incited by the declining housing market apparently swayed the Fed to take drastic […]
A study by the Tufts Center for the Study of Drug Development (CSDD) has found that the number of cancer drugs in clinical development has more than doubled between 1990 and 2006. However, only 8% of these drug candidates received marketing approval during the studied period. When broken down by compound type, market approval percentages […]
BTX Harvard Apparatus introduced the MicroPoration platform, consisting of a pulse generator, safety chamber and MicroPorator pipette, for nonviral transfection. Nova Biomedical launched the module BioProfile FLEX for cell culture analysis of 16 attributes. CellASIC launched the ONIX system for live cell imaging of yeast samples, featuring a microfluidic plate and flow control panel. Applied […]
Pay Invoice
Latest Blogs
-
New Report Details Higher Education Science R&D Spending
February 27, 2026 3:23 pm
-
Single Use Leads Bioreactor Market Growth
December 30, 2025 6:04 pm
Sitemap
Your Data and Privacy
About Us
IBO (Instrument Business Outlook) is a twice-monthly newsletter aimed at providing decision-makers with the latest and most complete information available on the life science and analytical instrument industry, and lab product markets. IBO delivers the latest curated industry news, information and trends, as well as SDi data and analysis to deliver the maximum in industry insight with a minimum time investment for executives and investors.
